{"id":27134,"date":"2025-08-05T12:30:00","date_gmt":"2025-08-05T16:30:00","guid":{"rendered":"https:\/\/tribu.la\/nzn-secures-6-6m-to-launch-biofertiliser-in-asia\/"},"modified":"2025-08-05T12:30:00","modified_gmt":"2025-08-05T16:30:00","slug":"nzn-secures-6-6m-to-launch-biofertiliser-in-asia","status":"publish","type":"post","link":"https:\/\/tribu.la\/pt\/nzn-secures-6-6m-to-launch-biofertiliser-in-asia\/","title":{"rendered":"NZN Secures $6.6M to Launch Biofertiliser in Asia"},"content":{"rendered":"<p>UK-based NetZeroNitrogen has raised $6.6 million to develop a bioinoculant for rice farming, aiming to reduce reliance on synthetic fertilizers. The funding will support product optimization and market entry in ASEAN countries, potentially transforming agricultural practices and enhancing farmer incomes.<\/p>\n<p><strong>Original excerpt:<\/strong> \u201cThe objective of our seed round is the launch of our first commercial product for rice&#8230;\u201d<\/p>\n<p><strong>Source:<\/strong> <a href=\"https:\/\/www.agtechnavigator.com\/Article\/2025\/08\/05\/british-biofertiliser-start-up-nzn-eyes-asia-after-raising-66mn\/\" target=\"_blank\" rel=\"noopener noreferrer\">AgTechNavigator.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>UK-based NetZeroNitrogen has raised $6.6 million to develop a bioinoculant for rice farming&#8230;<\/p>","protected":false},"author":16,"featured_media":27133,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_vp_format_video_url":"","_vp_image_focal_point":[],"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1035],"tags":[317,280],"content_format":[1036],"class_list":["post-27134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-global-innovation","tag-agtech","tag-biotech","content_format-summary"],"acf":{"content_format":1036},"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/tribu.la\/wp-content\/uploads\/2026\/07\/FSJYKDGQL5DHTNAEJJR4ON67NE.jpg","jetpack_sharing_enabled":true,"publishpress_future_action":{"enabled":false,"date":"2026-08-24 04:41:35","action":"category","newStatus":"draft","terms":[337],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts\/27134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/comments?post=27134"}],"version-history":[{"count":0,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/posts\/27134\/revisions"}],"acf:term":[{"embeddable":true,"taxonomy":"content_format","href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/content_format\/1036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/media\/27133"}],"wp:attachment":[{"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/media?parent=27134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/categories?post=27134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/tags?post=27134"},{"taxonomy":"content_format","embeddable":true,"href":"https:\/\/tribu.la\/pt\/wp-json\/wp\/v2\/content_format?post=27134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}